Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Preliminary results of the multicentre study on carbapenem resistance of Acinetobacter baumannii in northern Croatia (CROSBI ID 578981)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa

Bedenic B., Vranic-Ladavac M., Budimir A., Rezo-Vranjes V., Sivec S., Sijak D., Vranes J., Beader N., Kalenic S., Bosnjak Z. Preliminary results of the multicentre study on carbapenem resistance of Acinetobacter baumannii in northern Croatia // Abstracts of the 21st ECCMID / 27th ICC. 2011. str. S157-S157

Podaci o odgovornosti

Bedenic B., Vranic-Ladavac M., Budimir A., Rezo-Vranjes V., Sivec S., Sijak D., Vranes J., Beader N., Kalenic S., Bosnjak Z.

engleski

Preliminary results of the multicentre study on carbapenem resistance of Acinetobacter baumannii in northern Croatia

Objectives: The aim of the study was to characterize the mechanisms of carbapenem resistance in A. baumannii isolates collected in the frames of a multicenter study and to study their molecular epidemiology. Material and Methods: In total 115 A. baumannii isolates were collected in 13 diagnostic laboratories located in Northern part of Croatia in 2009. Antibiotic susceptibilities were determined by broth microdilution method according to CLSI. E-test MBL strips were used for detection of metallo-b-lactamases (MBLs). PCR was used to detect the presence of oxacillinases (OXA-51, OXA-23, OXA-24 and OXA-58) and MBLs of VIM, IMP and SIM series. The genetic context of blaOXA-51 and blaOXA-58 genes was determined by PCR mapping with the primers for ISAbaI and IsabaIII combined with forward and reverse primers for blaOXA-51 and blaOXA-58. Genotyping of the isolates was performed by PFGE. Results: There were 97% of the strains resistant to piperacillin, 94% to ceftriaxone, cefotaxime and gentamicin, 91% to ciprofloxacin, 89% to ceftazidime, 68% to tobramycin, 60% to amikacin and 29% to ampicillin/sulbactam. No resistance to colistin was observed. Colistin was the most potent antibiotic with MIC90 of 2 mg/L. Twelve isolates were found to be resistant to both carbapenems. Nine of them were shown to possess blaOXA58-like gene and three blaOXA-40 like gene. The strains susceptible to carbapenems were positive only for naturally ocurring OXA-51 b-lactamase whereas eight isolates with intermediate susceptibility to one or both carbapenems were shown to possess ISAbaI insertion sequence upstream of blaOXA-51 gene. No MBLs were found. Only OXA-58 b-lactamase was inhibited by sodium chloride. Chromosomal AmpC b-lactamases did not affect the susceptibility to carbapenems. None of the isolates exhibited significant synergy between meropenem and CCCP, indicating that overexpression of proton-gradient depended efflux pumps did not contribute to the meropenem resistance. The strains producing only OXA-51 b-lactamase were found to belong to EU clone I whereas OXA-40 and OXA-58 producers were asigned to EU clone II. Three strains positive for blaOXA-40 like genes were clonally related. Conclusions: The emergence of carbapenem resistance in A. baumannii in Northern Croatia is associated with the production of acquired oxacillinases belonging to OXA-58 and OXA-40 like groups. Carbapenem resistant isolates producing acquired oxacillinases belonged to EU clone II.

Acinetobacter; karbapenem; mechanism; resistant; hospital; strains

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

S157-S157.

2011.

objavljeno

Podaci o matičnoj publikaciji

Abstracts of the 21st ECCMID / 27th ICC

Podaci o skupu

21st ECCMID / 27th ICC

poster

07.05.2011-10.05.2011

Milano, Italija

Povezanost rada

nije evidentirano